Skip Content
You are currently on the new version of our website. Access the old version .
  • Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
  • Article
  • Open Access

5 February 2009

Isolation and Characterization of an Impurity Obtained During the Synthesis of the Antibiotic Drug Sparfloxacin

,
,
,
,
and
1
Department of Analytical Research, Discovery Research, Dr. Reddy’s Laboratories, Miyapur, Hyderabad 500 049, India
2
Process R&D, Custom pharmaceutical synthesis-II, Dr. Reddy’s Laboratories Ltd., Jeedimetla, Hyderabad, India
3
Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500072, India
*
Author to whom correspondence should be addressed.

Abstract

During the synthesis of Sparfloxacin, a fluoroquinolone antibiotic drug, an unknown impurity (SF5-IMP) was identified in the fifth stage of the synthetic process. The impurity has been isolated from the mother liquor of intermediate SF5. The mother liquor was concentrated to dryness added dichloromethane and stirred for 1 h and filtered to generate SF5-IMP and the molecular structure was elucidated as 7-amino-1-cyclopropyl-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline- 3-carboxylic acid by 19F NMR and single crystal X-ray diffraction studies. The structural features of SF5-IMP and SF5 have been discussed here.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.